Join us at Health Research Day — June 6th at Canton Waterfront Park, Baltimore!   Learn More →
← Back to all trials
Not Yet Recruiting NCT05651685

Treatment Recommendations for Patients With ADHD TDApp2

Conditions: Attention Deficit Disorder With Hyperactivity

Sex: All
Ages: 6 Years – 17 Years
Enrollment: 32
Sponsor: Universitat de Girona

Location: Spain

Summary

The purpose of this study is to compare the recommendations made by TDApp2 with those by relevant clinical practice guidelines in children/adolescents with ADHD.

Eligibility Criteria

Inclusion Criteria:Patients aged 6-17 yoMeeting DSM 5 criteria for ADHDRequiring treatment initiation for ADHD or requiring a treatment changeExclusion Criteria:Patients who are receiving treatment for ADHD and who are well controlled with itPatients who do not have a suitable electronic device for TDApp2

Interested in this study? View the official listing for contact and enrollment details.

View on ClinicalTrials.gov

Source: ClinicalTrials.gov (NCT05651685). StuddyBuddy aggregates publicly available trial information.